Accelerate novel therapy discovery by identifying true drug targets with AI-driven causal biology.

"The Opal Platform has fundamentally changed how we approach target identification. The AI's ability to surface biologically relevant connections based on causal biology is unprecedented, saving us immense time in experimental validation and leading us to more promising avenues."

"While the success-based model requires clear communication on milestones, the platform's predictive power for candidate selection is invaluable. We've seen a noticeable reduction in early-stage attrition since implementing Opal."

"Opal's knowledge graphs provide a level of insight into disease pathways that was previously unattainable. It allows us to explore complex biological questions and identify novel intervention points with greater confidence and speed."

"The integration of AI with human biology is a critical differentiator. It streamlines our early discovery process, making investments more judicious and increasing our confidence in advancing promising therapeutic candidates."